A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...
By making the 2026 Milan Cortina Winter Olympics, the former Hawks track star turned bobsledder 'shows that anything’s ...
A prize signature for a modern Welsh autograph book may be Gareth Bale or Michael Sheen, but for one teenager during World ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
22hOpinion
Gavin Newsom Is Setting His Own Rules
Then there’s the stuff Newsom has been doing. Forcing the president to backtrack on deploying the National Guard to Los ...
Greenlight Capital, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter ...
"My old millionaire boss picked a penny up off the workshop floor, handed it to me, and said, 'There's your wages,' then ...
Takeda Canada Inc. (“Takeda”) is pleased to announce that Ontario Drug Benefit (ODB) include FruzaqlaTM (fruquintinib capsules) in the list of drugs eligible for ...
Irvine-based ophthalmic company SpyGlass filed for an initial public offering with the Securities and Exchange Commission earlier this month.
Roche’s Genentech plans to start its Phase 3 this quarter, but primary completion will happen by 2028. Click here to find out ...
Zacks Investment Research on MSN
5 low price-to-book stocks that are worth watching in February
Finding true value stocks is rarely straightforward. While tracking key financial indicators such as earnings per share and sales growth can help investors spot stocks trading below their intrinsic ...
ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results